News

Luna Labs’ MedSim Product Lines Acquired by Integrated Medcraft

Integrated MedCraft LLC today announced it has acquired the TrueClot and Dislotech product lines from Luna Labs. This announcement is more than a successful transaction. It is an example of innovation being accelerated with the right strategic partner.

We built Luna Labs with a clear mission to incubate, accelerate, and grow technologies to the point where they are poised to achieve their full potential. This acquisition demonstrates that our strategy is working as intended.

What started as an SBIR project to create a realistic blood simulant for the Department of Defense has evolved into TrueClot Bleeding Control Training Products. Routinely used to train professional first responders, law enforcement, and combat medics, the market opportunity is bigger than our company can address alone. This acquisition ensures these products will reach the scale and impact they deserve.

Dislotech Joint Reduction Trainers are also ready for growth, offering athletic trainers and medical professionals the opportunity for hands-on joint reduction training prior to practice on patients.

“I am proud of what our Luna Labs’ MedSim team has accomplished,” said Michael Danilich, PhD, Sr. VP of Operations at Luna Labs, and Principal Investigator, TrueClot. “We didn’t just create products, we created new training standards. It’s been rewarding to watch TrueClot grow from a concept to a suite of tools trusted around the world – that’s the kind of impact we strive to achieve.”

This evolution required relentless determination from our development, operations, sales, marketing, and manufacturing teams. They built the most realistic bleeding control and joint reduction training tools available, and their work set a new benchmark for emergency responder training. Congratulations to Brad Day, Kevin Tate, Joe Cattell-Gordon, Ron Wenzel, Keyanna Grayson, Dana Rich, Lianne Landers, Kelley Virgilio, Matt Patterson, Christopher Tison, PhD, MBA, and many others who contributed to this success.

The transition will be seamless with operations, personnel, and manufacturing staying in Charlottesville. TrueClot and Dislotech products will be sold as part of Integrated Medcraft’s full product portfolio and available to emergency response training markets worldwide.

 

Read more here.

Recent News

04/08/2026

Likarda and The Tiny Cargo Company Announce Strategic Partnership to Advance Next-Generation Delivery of Biologics, Peptides and Small Molecules

Likarda, Inc., a leader in hydrogel-based drug delivery technologies, today announced a strategic partnership with Tiny Cargo, an innovator in extracellular vesicle (EV) delivery systems. The collaboration will focus on advancing the delivery of biologics and small molecules by integrating Likarda’s Core-Shell Spherification® (CSS®) platform with Tiny Cargo’s vesicle-based technologies. The partnership is designed to

04/08/2026

ReAlta Life Sciences Closes Oversubscribed $40 Million Financing Round to Advance Pegtarazimod Phase 2 Program in Hypoxic Ischemic Encephalopathy (HIE)

ReAlta Life Sciences Inc. (“ReAlta” or the “Company”), a clinical-stage biopharmaceutical company focused on safely targeting neutrophils and central components of the complement system to potentially revolutionize the treatment of inflammatory disorders, today announced the closing of an oversubscribed $40 million financing. This brings the total capital raised to date to more than $150 million.

04/02/2026

ATCC Receives New CDC Award to Help Fast-track Diagnostic Tests for Future Disease Outbreaks

TCC has been selected by the Centers for Disease Control and Prevention (CDC) Office of Readiness and Response (ORR) for a new five-year contract to support rapid test development during public health emergencies. The award, valued at up to $148 million (IDIQ contract 75D301-25-R-73207), will help ensure that diagnostic tools can be quickly created, validated,